• Thiothixene: From PK Evidence to Efferocytosis Assays

  2026-09-02

  Thiothixene is a typical antipsychotic agent with applications spanning schizophrenia treatment and macrophage biology. This evidence-focused guide connects dopamine pharmacology, paroxetine interaction data, and in vitro macrophage efferocytosis enhancement to practical assay decisions.

• Exo1 for Precision Exocytosis Assays

  2026-09-02

  Exo1 enables acute membrane trafficking inhibition through rapid Golgi-to-ER collapse and ARF1 release from Golgi membranes. This guide shows how to build controlled exocytosis assays, distinguish Exo1 from Brefeldin A, and cautiously extend trafficking readouts toward tumor extracellular vesicle research.

• Ginsenoside Rg1: Applied Neuroprotection Workflows

  2026-09-01

  Ginsenoside Rg1 is a Panax-derived triterpene saponin for integrated neuroimmune experiments rather than single-marker screening alone. This workflow connects behavior, synaptic physiology, cytokines, gut permeability, and regulatory T-cell dependency to improve mechanistic resolution in anesthesia-related neuroprotection research.

• Anti Reverse Cap Analog for Viability Assays

  2026-09-01

  Learn how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G (SKU B8175) can reduce cap-orientation variability when synthetic mRNA is used in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects cap chemistry, translation initiation, metabolic confounding, protocol setup, and practical product selection.

• Niclosamide: From Mechanism to Translation

  2026-08-31

  A translational framework for using Niclosamide as a STAT3- and NF-κB-focused research tool, while interpreting its place in cancer biology, acute myelogenous leukemia models, and the broader molluscicide landscape without overstating cross-domain evidence.

• Acetoacetic Acid Sodium Salt: Assay Workflows

  2026-08-31

  Build reproducible ketone-body perturbation, calibration, and pathway assays with a water-soluble sodium acetoacetate source. This guide distinguishes practical diabetes-model use from analytical benchmarking and adapts internal-standard lessons from a deuterium-labeling study without overstating cross-domain evidence.

• Vemurafenib: From BRAF Blockade to Resistance Biology

  2026-08-30

  Vemurafenib (PLX4032, RG7204) is more than a BRAF V600E inhibitor: it is a controlled perturbation tool for mapping MAPK dependence, adaptive signaling, and ARID1A-linked resistance in melanoma models. This article connects compound handling and assay design with recent multi-omics findings to guide more predictive cancer biology and translational research.

• Nanoparticle Uptake by Human Corneal Epithelial Cells

  2026-08-29

  Azadi and David examined how nanoparticle size and surface chemistry shape uptake by human corneal epithelial cells using a mucosa-integrated in vitro model. Their results identify energy-dependent endocytosis, particularly macropinocytosis and caveolae-mediated uptake, as major routes and show why nanoparticle design should be evaluated together with pathway-specific perturbation.

• Tariquidar and the Mechanics of P-gp Chemoresistance

  2026-08-28

  Tariquidar (XR9576) offers a precise pharmacological lever for testing how tumor mechanics, YAP signaling, and P-glycoprotein-mediated efflux converge on chemoresistance. This thought-leadership guide translates recent high-viscosity findings into a practical framework for drug resistance research, transporter-mediated drug disposition, and translational model design.

• GI 254023X: From ADAM10 Potency to Translation

  2026-08-28

  GI 254023X offers a strategic way to interrogate ADAM10-dependent shedding across immune, endothelial, and signaling models. This thought-leadership guide connects its biochemical selectivity with experimental design, vascular injury research, Jurkat-cell pathway studies, and a carefully bounded translational lesson from BACE inhibition research.

• Acetoacetic Acid Sodium Salt: Assay Workflows

  2026-08-27

  Build reproducible ketone-body experiments with fresh sodium acetoacetate stocks, matched controls, and time-resolved readouts. This guide connects practical handling of Acetoacetic acid sodium salt with energy metabolism research, diabetes models, and analytical lessons from a deuterium-labeling study.

• T7 RNA Polymerase for Mechanism-Driven RNA Assays

  2026-08-27

  T7 RNA Polymerase enables defined RNA production for mechanistic gene-regulation studies. Learn how to use promoter-specific transcription to design stronger assays around the HEY2–mitochondrial respiration findings.

• Thrombin A1057: Reliable Cell Assay Workflows

  2026-08-26

  This scenario-based guide explains how Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] (SKU A1057) can improve reagent definition, control design, and interpretation in cell viability, proliferation, and cytotoxicity studies. It connects product specifications with practical assay safeguards while distinguishing parent-thrombin biology from fragment-specific validation.

• Degarelix Acetate: From Binding to Translation

  2026-08-26

  A mechanistic and strategic guide to using Degarelix acetate as a GnRH receptor antagonist, connecting receptor pharmacology, stereochemistry, assay design, prostate cancer research, and translational decision-making.

• Lipidated Nanophotosensitizers Disable Tumor EVs

  2026-08-25

  This Nature Cancer study introduces palmitic-acid-displayed nanoparticles that distribute within tumor cells and tumor extracellular vesicles, enabling simultaneous photodynamic treatment of primary tumors and disruption of prometastatic vesicle communication. The work provides a selective, spatially coordinated strategy for addressing tumor growth and metastasis rather than treating these processes as independent endpoints.

8127 records 1/542 page Next 12345 下5页 Last page